The Innovation Firm

Rebecca L. Simmons, Ph.D.

Practice Areas

Technologies

Education

  • Boston College, B.S. in Chemistry, summa cum laude
  • Boston College, B.S. in French, summa cum laude
  • Harvard University, Ph.D. in Chemistry
  • Boston University School of Law, J.D. Expected May 2018

Professional Associations

  • Boston Patent Law Association

Rebecca L. Simmons, Ph.D.

Rebecca L. Simmons, Ph.D. Attorney

Rebecca L. Simmons, Ph.D.

Patent Agent
Concord office
978.341.0036

Rebecca assists with patent preparation and prosecution in the areas of biotechnology, chemistry, mechanical, and pharmaceuticals.  In the pharmaceutical field, Rebecca has particular experience with the preparation and prosecution of both U.S. and foreign patents involving small molecules, antibiotics, and anti-cancer drugs.  She also has experience with patents involving devices for use within the pharmaceutical and semiconductor industries, and with process patents in the chemical arts. Rebecca has also assisted extensively in patent litigation and in the preparation of freedom-to-operate and invalidity opinions.

Specifically, Rebecca has assisted in filing and managing the patent portfolio of an emerging pharmaceutical company for new therapeutics currently undergoing clinical trials for use in cancer, and in guiding the company through their Initial Public Offering.  She has also assisted in the management of the worldwide patent portfolio of a mature pharmaceutical company, and has worked extensively with both French and French-American clients in the areas of pharmaceuticals and biotechnology.  In addition, Rebecca has coordinated ongoing prosecution for the patent portfolio of a mature life sciences company related to a co-pending litigation, ensuring coherence between litigation and prosecution strategies and compliance with duty of disclosure of Court filings and decisions.  Rebecca has also worked with inventors at several large research universities to patent their inventions.

As a graduate student at Harvard University, Rebecca developed a strategy for bioconjugation based on the synthesis of a stable, biotin-tagged organopalladium(II) reagent that reacts with alkene-containing probes in complex proteomic mixtures and used the approach to isolate the known protein targets of two natural products in pull-down experiments.

Prior to completing her Ph.D., Rebecca worked in the Research Division at Hitachi Global Storage Technology and in the Storage Technology Division at IBM.  She also worked as an undergraduate research assistant at Boston College and Ecole Superieure de Physique et de Chimie Industrielles in Paris, France.  At Ecole Superieure de Physique et de Chimie Industrielles, she assessed the chemoselectivity of a series of cross metathesis reactions catalyzed by the Hoveyda–Grubbs metathesis catalyst, and at Boston College, she focused on understanding the reactivity preferences of Mo-based metathesis catalysts, extending Grubbs’ model of selective Ru-catalyzed cross-metathesis to Mo-based catalysts.

Rebecca has been the recipient of many awards and honors, including the Eli Lilly Organic Chemistry Fellowship, Robert B. Woodward Fellow, Fulbright Foreign Scholarship, Presidential Scholarship Program, and the IBM Thomas J. Watson Memorial Scholarship Award.  She is also fluent in French.

Rebecca is a co-inventor on U.S. Patent Application No. 2007/0089995 A1, “Damascene Copper Plating for Coils in Thin Film Heads.”  She has also co-authored publications that appeared in The Journal of the American Chemical Society and Organic Letters.

Bar Admissions

  • U.S. Patent and Trademark Office
  • Rebecca L. Simmons, Ph.D., Joins Hamilton Brook Smith Reynolds as a Technology Specialist more
Biography

Rebecca assists with patent preparation and prosecution in the areas of biotechnology, chemistry, mechanical, and pharmaceuticals.  In the pharmaceutical field, Rebecca has particular experience with the preparation and prosecution of both U.S. and foreign patents involving small molecules, antibiotics, and anti-cancer drugs.  She also has experience with patents involving devices for use within the pharmaceutical and semiconductor industries, and with process patents in the chemical arts. Rebecca has also assisted extensively in patent litigation and in the preparation of freedom-to-operate and invalidity opinions.

Specifically, Rebecca has assisted in filing and managing the patent portfolio of an emerging pharmaceutical company for new therapeutics currently undergoing clinical trials for use in cancer, and in guiding the company through their Initial Public Offering.  She has also assisted in the management of the worldwide patent portfolio of a mature pharmaceutical company, and has worked extensively with both French and French-American clients in the areas of pharmaceuticals and biotechnology.  In addition, Rebecca has coordinated ongoing prosecution for the patent portfolio of a mature life sciences company related to a co-pending litigation, ensuring coherence between litigation and prosecution strategies and compliance with duty of disclosure of Court filings and decisions.  Rebecca has also worked with inventors at several large research universities to patent their inventions.

As a graduate student at Harvard University, Rebecca developed a strategy for bioconjugation based on the synthesis of a stable, biotin-tagged organopalladium(II) reagent that reacts with alkene-containing probes in complex proteomic mixtures and used the approach to isolate the known protein targets of two natural products in pull-down experiments.

Prior to completing her Ph.D., Rebecca worked in the Research Division at Hitachi Global Storage Technology and in the Storage Technology Division at IBM.  She also worked as an undergraduate research assistant at Boston College and Ecole Superieure de Physique et de Chimie Industrielles in Paris, France.  At Ecole Superieure de Physique et de Chimie Industrielles, she assessed the chemoselectivity of a series of cross metathesis reactions catalyzed by the Hoveyda–Grubbs metathesis catalyst, and at Boston College, she focused on understanding the reactivity preferences of Mo-based metathesis catalysts, extending Grubbs’ model of selective Ru-catalyzed cross-metathesis to Mo-based catalysts.

Rebecca has been the recipient of many awards and honors, including the Eli Lilly Organic Chemistry Fellowship, Robert B. Woodward Fellow, Fulbright Foreign Scholarship, Presidential Scholarship Program, and the IBM Thomas J. Watson Memorial Scholarship Award.  She is also fluent in French.

Rebecca is a co-inventor on U.S. Patent Application No. 2007/0089995 A1, “Damascene Copper Plating for Coils in Thin Film Heads.”  She has also co-authored publications that appeared in The Journal of the American Chemical Society and Organic Letters.

Education
  • Boston College, B.S. in Chemistry, summa cum laude
  • Boston College, B.S. in French, summa cum laude
  • Harvard University, Ph.D. in Chemistry
  • Boston University School of Law, J.D. Expected May 2018
Professional Associations
  • Boston Patent Law Association
News
  • Rebecca L. Simmons, Ph.D., Joins Hamilton Brook Smith Reynolds as a Technology Specialist more
Bar Admissions
  • U.S. Patent and Trademark Office

Back to the Top